Hong Kong urged to extend stock trading hours to keep up with rivals

    Hong Kong urged to extend stock trading hours to keep up with rivals

    Hong Kong has been urged to extend its stock trading hours to maintain its status as an international financial hub, as competitors move towards near 24-hour operations to capture global liquidity. Speaking at the “Redefining Hong Kong 2026 Budget Edition” forum organised by the South China Morning Post on Monday, Kenny Shui Chi-wai, vice-president of…

    Read More
    Hong Kong IPO market eyes HK$300 billion in 2026

      Hong Kong IPO market eyes HK$300 billion in 2026

      People walk past the Exchange Square, which houses the Hong Kong Stock Exchange, in Central, Hong Kong, Aug 20, 2025. (EDMOND TANG / CHINA DAILY) Hong Kong’s initial public offering (IPO) market staged a strong rebound in 2025, with 114 listings raising about HK$286.3 billion ($36.78 billion) — a 63 percent jump in deals and…

      Read More
      Jennifer Garner's baby food company is going public on the NYSE — should investors be putting their eggs in this basket?

      Jennifer Garner’s baby food company is going public on the NYSE — should investors be putting their eggs in this basket?

      Co-founded by Jennifer Garner, Once Upon A Farm, a Berkeley, California-based organic baby food company, recently announced its Initial Public Offering (IPO) filing. Pending SEC approval, it will list its common stock on the New York Stock Exchange with the ticker “OFRM”. According to its filing, Once Upon A Farm saw its six-month revenue increase…

      Read More
      Analysis-AstraZeneca's US listing may pull other firms from London in its wake

      Analysis-AstraZeneca’s US listing may pull other firms from London in its wake

      By Charlie Conchie LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from London’s stock market and could pave the way for other large companies to follow suit, analysts, investors and advisers said. The British drugmaker, one of London’s most valuable listed companies, said on Monday it would retain…

      Read More